Policy

National Security Framework of Antarctica (NSF-A)

1) Scope & Purpose

Establishes electronic, license-gated controls over alcohol, tobacco products, and controlled drugs across procurement, storage, movement, and use. This protocol integrates identity, attestation, and telemetry to protect public health and national security.

2) Domestic Market Rules (Antarctica)

1. Total Prohibition: The manufacture, import, sale, gifting, advertising, possession for sale, or dispensing of alcoholic beverages, combustible tobacco, smokeless tobacco, and controlled drugs is prohibited.
2. Single Exception — e-Vape Protocol:
3. Form factor: Monodose (single-use dose or sealed single-cartridge) only.
4. Colour/Branding: Black, unbranded housings; no colour variants, lights, gradients, or promotional graphics.
5. Nicotine/Contents: Nicotine concentration and excipients must meet DCF toxicology limits; flavour catalogue restricted to non-youth-appeal profiles; full ingredient disclosure.
6. Distribution: Medical/cessation channels only; age-verified; per-person monthly cap; take-back for safe disposal.
7. Devices: Must pass MPSL pre-boot checks and register to the Civilian DMZ network for traceability.

Medical/Research Exemptions: Schedule-controlled substances may be handled only under NSF-A licences (BPL/CSC), in secure facilities, for approved clinical or scientific protocols—no retail or consumer access.

3) Foreign Market (Exports Only)

1. Authorised Categories: Class A controlled drugs (for lawful medical/clinical supply) and alcoholic products may be exported where a valid international agreement/MoU exists and all partner-jurisdiction laws and export controls are met.
2. Hard Requirements:
3. Exporter must hold Commercial Science Licence (CSL) (L3 baseline; Bachelor-level for contracts > £75,000; Advanced CSL + independent risk review for > £3,000,000).
4. End-use and end-user declarations; sanctions screening; AML/KYT telemetry; tamper-evident logistics; recall plans.
5. No diversion back into Antarctica.

4) Domestic Alcohol Review & Pilot (Bars)

Public feedback noted strong objection to blanket restrictions on wine, rum, whiskey, and beer. The authority has accepted a policy review and will run a limited, blockchain-secured dispensing pilot (“Bar-Limited Dispensing Pilot”, BLDP).

4.1 Pilot Status

1. Until pilot launch, the domestic alcohol prohibition remains in force.
2. Pilot venues and dates will be gazetted separately.

4.2 Blockchain Security Controls (Design Mandates)

1. Identity & Age: State ID with liveness; privacy-preserving proofs (ZK) confirm eligibility without exposing full PII to venues.
2. Daily Allowance Smart Contract: Per-person tokenised allowance (e.g., “Alcohol Units/Day”). Hard cap (configurable), non-transferable, resets daily; venue cannot serve above allowance.
3. Sobriety Gate: On-prem device (breath/impairment check) writes a pass/fail oracle to the contract before each round. Fail = lockout until safe window.
4. Geofencing & Time Windows: Serving only within licensed geofenced premises and allowed hours; off-premise consumption locked out.
5. Menu Telemetry: Each product mapped to unit equivalents; pour size scanned/verified (smart pourers/QR).
6. Anti-Structuring: Rapid multi-venue attempts trigger rate-limit across the network.
7. Refund/Chargeback Logic: Unpoured transactions auto-revert; poured = final.
8. Audit: Append-only, regulator-read ledger for public-health analytics; venue sees only minimal data needed to serve.

4.3 Venue & Staff Requirements

1. Licensing: ERP-ATCS Bar Pilot Licence + DIL (for device connectivity) + CSL per §3.
2. Training: Intoxication recognition, refusal and safeguarding; device ops; incident reporting.
3. Sanctions: Over-serving, bypassing devices, or tampering → immediate suspension; criminal referral for wilful breach.

5) Packaging, Advertising & Presentation

1. Domestic: No advertising of alcohol/tobacco; neutral packaging for medical e-vapes; plain warnings; no lifestyle imagery.
2. Exports: Must meet importing country’s labelling plus NSF-A traceability watermarks and origin hashes.

6) Licences & Compliance (Summary)

1. Domestic handling (medical/research): BPL/CSC.
2. Digital/venue infrastructure: Digital Infrastructure Licence (DIL).
3. Commercial negotiations: CSL thresholds apply as above.
4. Device compliance: MPSL attestation + Civilian DMZ registration.
5. Audits: SBOMs, supply-chain proof, red-team attestations, waste/disposal logs.

7) Waste, Returns & Recall

1. E-vapes: Mandatory take-back; tracked destruction (battery & nicotine handling).
2. Alcohol (pilot & exports): Lot-level recall capability; expired stock destruction under witness.

8) Offences & Penalties (Antarctica)

1. Domestic contraband (sale/possession for sale/advertising): Seizure, fines, licence revocation, imprisonment per the Sanctions Code.
2. Colourful e-vapes in domestic market: Product seizure; per-unit civil penalty; importer blacklisting.
3. Pilot tampering/over-serving: Venue shutdown; criminal referral; officer blacklisting.

Appeals: File within 15 working days; emergency actions are not stayed pending appeal.

9) Data Protection & Public Health

1. Minimisation: Venues access only eligibility and remaining units; regulator holds de-identified analytics for harm minimisation.
2. Transparency: Publish redacted quarterly metrics (pilot only): participation, refusals, incidents, medical referrals.

10) Implementation & Timeline

1. Phase 1 (Now): Domestic prohibition + e-vape protocol live; export framework active under agreements.
2. Phase 2 (Pilot Readiness): Certify devices, smart contracts, venues, and staff; public notice of BLDP.
3. Phase 3 (Pilot): Time-boxed evaluation with health KPIs; independent review to determine permanent policy.

11) Contacts

1. Licensing (ERP-ATCS/Bar Pilot): licensing@nsf-antarctica.org
2. Compliance & Audits: compliance@nsf-antarctica.org
3. Public Health & Policy Review: health@nsf-antarctica.org
4. Whistleblowing (24/7): report@nsf-antarctica.org

Until the Bar-Limited Dispensing Pilot is formally announced, all domestic alcohol activity remains prohibited. The e-vape exception is limited to black monodose devices via medical/cessation channels, under the DCF.

Version 1.0 • Effective 26 September 2025